Analyze Diet
Journal of virological methods1995; 54(1); 39-49; doi: 10.1016/0166-0934(95)00024-o

A mouse model for testing the pathogenicity of equine herpes virus-1 strains.

Abstract: A mouse model was developed for testing the pathogenicity of equine herpes virus-1 (EHV-1) strains. The model was validated with EHV-1 strains that are known to be of a low or high pathogenicity in horses. From all parameters tested, the safety index, which was calculated from the body weights of the mice after infection, proved to be the best predictive parameter. When this parameter was used, good and reliable correlations were found with the pathogenicity of the EHV-1 strains in horses. This method enabled the differentiation between the two experimental EHV-1 strains whose genetic backgrounds were supposedly equal.
Publication Date: 1995-07-01 PubMed ID: 7559856DOI: 10.1016/0166-0934(95)00024-oGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The paper discusses a mouse model created for evaluating the pathogenicity of equine herpes virus-1 (EHV-1) strains, showing that the model’s predictive parameter—the safety index derived from mouse body weight post-infection—accurately correlates with EHV-1’s pathogenicity in horses.

Mouse Model Development

  • The researchers established a mouse model intended to test the pathogenicity (ability to cause disease) of equine herpes virus-1 (EHV-1) strains.
  • The purpose of this model is to provide a reliable alternative testing method, ideally enhancing understanding and prediction of the pathogenicity of EHV-1 strains.

Validation of Mouse Model

  • The model was validated by testing it with known EHV-1 strains; these strains are already delineated based on their low or high pathogenicity in horses.
  • The model’s effectiveness was determined by its ability to accurately represent the known pathogenicity of these strains, demonstrating its potential use as an assessment tool.

Determining the Best Predictive Parameter

  • The researchers evaluated various parameters to identify which one could best predict EHV-1 pathogenicity within the mouse model.
  • The ‘safety index’ was identified as the most reliable predictive parameter. This index was calculated using the body weight changes of the mice after being infected with the EHV-1 strains.

Correlation with EHV-1 Pathogenicity in Horses

  • When the safety index was employed as the predictive parameter in the mouse model, the researchers found strong correlations with the pathogenicity of EHV-1 strains in horses.
  • This suggests that the mouse model can accurately reflect and predict the strains’ pathogenicity levels when they infect horses.

Assessing Different EHV-1 Strains

  • The model’s reliability and predictive power were further tested by distinguishing between two EHV-1 strains, both of which had supposedly homogenized genetic backgrounds.
  • The differentiation between these strains signifies the model’s potential to provide detailed insights into the pathogenicity of diverse EHV-1 strains even when their genetic backgrounds appear identical.

Cite This Article

APA
van Woensel PA, Goovaerts D, Markx D, Visser N. (1995). A mouse model for testing the pathogenicity of equine herpes virus-1 strains. J Virol Methods, 54(1), 39-49. https://doi.org/10.1016/0166-0934(95)00024-o

Publication

ISSN: 0166-0934
NlmUniqueID: 8005839
Country: Netherlands
Language: English
Volume: 54
Issue: 1
Pages: 39-49

Researcher Affiliations

van Woensel, P A
  • Department of Virological Research and Development, Intervet International B.V., Boxmeer, Netherlands.
Goovaerts, D
    Markx, D
      Visser, N

        MeSH Terms

        • Animals
        • Body Weight
        • Cell Line
        • Disease Models, Animal
        • Herpesviridae Infections / diagnosis
        • Herpesviridae Infections / veterinary
        • Herpesviridae Infections / virology
        • Herpesvirus 1, Equid / isolation & purification
        • Herpesvirus 1, Equid / pathogenicity
        • Horse Diseases / virology
        • Horses
        • Lung / pathology
        • Mice
        • Mice, Inbred BALB C

        Citations

        This article has been cited 4 times.
        1. Mashin VV, Sergeev AN, Martynova NN, Oganov MD, Sergeev AA, Kataeva VV, Zagidullin NV. Ensuring Viral Safety of Equine Immunoglobulins during Production.. Pharm Chem J 2022;56(2):283-288.
          doi: 10.1007/s11094-022-02632-zpubmed: 35571872google scholar: lookup
        2. Shakya AK, O'Callaghan DJ, Kim SK. Comparative Genomic Sequencing and Pathogenic Properties of Equine Herpesvirus 1 KyA and RacL11.. Front Vet Sci 2017;4:211.
          doi: 10.3389/fvets.2017.00211pubmed: 29312962google scholar: lookup
        3. Liu SA, Stanfield BA, Chouljenko VN, Naidu S, Langohr I, Del Piero F, Ferracone J, Roy AA, Kousoulas KG. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.. J Virol 2017 Jun 15;91(12).
          doi: 10.1128/JVI.02445-16pubmed: 28404844google scholar: lookup
        4. Fulton A, Peters ST, Perkins GA, Jarosinski KW, Damiani A, Brosnahan M, Buckles EL, Osterrieder N, Van de Walle GR. Effective treatment of respiratory alphaherpesvirus infection using RNA interference.. PLoS One 2009;4(1):e4118.
          doi: 10.1371/journal.pone.0004118pubmed: 19122813google scholar: lookup